A B S T R A C T Because human erythrocyte membrane Ca2+-ATPase is a calmodulin-dependent enzyme, and because physiological levels of thyroid hormone stimulate this enzyme system in vitro, we have studied the role of calmodulin in this model of extranuclear thyroid hormone action. Ca2+-ATPase activity in the absence of thyroid hormone ("basal activity") was increased by inclusion in the preassay incubation mixture of purified calmodulin or hypothyroid erythrocyte hemolysate that contained calmodulin (39 jig calmodulin/ml packed cells, determined by radioimmunoassay); addition of L-thyroxine or 3,5,3'-triiodo-L-thyronine (10-10 M) significantly enhanced (P < 0.001) enzyme activity in the presence of calmodulin or hemolysate. The stimulatory effects of thyroid hormone, calmodulin, and hemolysate were additive. At 5-10 MM, trifluoperazine, an antagonist of calmodulin, inhibited thyroid hormone stimulation of Ca2+-ATPase activity. Higher concentrations of trifluoperazine (50-100 MM) inhibited basal and hormone-stimulated enzyme activity, with or without added calmodulin. Anti-calmodulin antibody (10-50 yg antibody/mg membrane protein) inhibited basal, calmodulin-stimulated and thyroid hormone-stimulated Ca2+-ATPase activity. Membrane preparations were shown by radioimmunoassay to contain residual endogenous calmodulin (0.27±0.02 jg/mg membrane protein). The latter accounts for the effect of trifluoperazine and calmodulin antibody on membrane Ca2+-ATPase activity in the absence of added purified calmodulin.
INTRODUCTION
The stimulation in vitro by physiological concentrations of thyroid hormone (1010 to 10-12 M) of human erythrocyte Ca2_-stimulated, Mg2+-dependent adenosine triphosphatase (Ca2+-ATPase)1 activity has recently been described by this laboratory (1) . The action of L-thyroxine (T4) on this membrane transport-associated enzyme does not require prior conversion of T4 to 3,5,0'-triiodo-L-thyronine (T3) (1) . The effect of io- dothyronines in this system is species-dependent (2) and is specific for T4, T3 and certain structural analogs, such as 3,5-dimethyl-3'-isopropyl-L-thyronine (DIMIT) (3) . lodothyronines such as 3,3',5'-L-T3 (reverse T3), 3,5,3'-triiodothyroacetic acid, D-T3 and D-T4 (3) do not stimulate Ca2+-ATPase activity. Because Ca2+-ATPase in the human erythrocyte is a calmodulin-dependent enzyme (4), we have conducted a series of in vitro studies to determine the role of calmodulin in this extranuclear action of thyroid hormone. METHODS Erythrocyte membranes. Heparinized blood samples were obtained from euthyroid human volunteers by a protocol approved by the institutional Human Research Committee. Washed erythrocyte membranes ("ghosts") were prepared in hypotonic Tris buffer (10 mM) in the presence of EDTA (0.1 mM), as previously described (1) . This method results in membranes with low residual calmodulin content (4) . Ghosts were stored for 24 -72 h at -70'C until used. Previous studies have shown that the washing process removes >99% of endogenous thyroid hormone bound to erythrocyte membranes (1) .
In a separate series of experiments, erythrocyte membranes were prepared in imidazole buffer by the method of Jarrett and Penniston (5) . Hormones (6) and T3 (7) in hemolysate revealed no In each assay were included blanks for nonenzymatic hydrolysis of ATP and liberation of phosphate from erythrocyte membranes. In experiments involving hemolysate, background phosphate content of these fractions was subtracted from ATP hydrolysis measurements.
In selected studies, the Ca2+-ATPase activity of erythrocyte membranes was assayed according to the method of Jarrett and Penniston (5) . In this assay, carried out in imidazole buffer, enzyme activity is measured as the difference between micromoles P1 liberated/milligram membrane protein/15-min assay period, in the presence and absence of calcium.
Calmodulin radioimmunoassay. The calmodulin content of solubilized erythrocyte membranes and hypothyroid hemolysate was determined by radioimmunoassay according to the method of Chafouleas et al. (11) , utilizing 0.5 ml Triton X-100/500 ml of homogenization and assay buffers to avoid gel formation in the hemolysate.
Statistical significance of the thyroid hormone effect was determined by paired t test. The enzyme activity of each sample incubated with T4 was compared with that of a simultaneous control sample without T4 (basal activity), and the significance of the difference between the two activity levels (that is, the change with T4, or A T4) was determined. (1, 3, 12) .
RESULTS

Stimulation
Because basal enzyme activity can be materially affected by the method of membrane preparation (4), we compared the Ca2+-ATPase activity of membranes prepared by our method (Tris buffer) with the activity of erythrocyte membranes prepared by the method of Jarrett and Penniston (5); both sets of membranes were obtained from the same donor and assayed in the same experiment. The technique of Jarrett and Penniston depends upon hypotonic lysis of cells in water, followed by membrane washes in imidazole buffer. Comparison of the enzyme activities obtained from the two preparations is shown in Table II , part A, and indicates that the imidazole-prepared membranes have approximately 2.5-fold the basal activity of Tris-prepared ghosts when both sets of membranes are assayed for Ca2+-ATPase in Tris. Significant stimulation of membrane enzyme activity by T4 is observed when membranes are prepared in imidazole and assayed in Tris. However, use of imidazole buffer in the enzyme assay system, when ghosts were prepared in Tris, resulted in no basal Ca2+-ATPase activity and no thyroid hormone-stimulability of the enzyme (Table II, Effect of erythrocyte hemolysate on Ca2+-ATPase activity. In the absence of added thyroid hormone, incubation of hypothyroid erythrocyte hemolysate with ghosts (10 pl hemolysate/mg membrane protein) resulted in significant enhancement of Ca2+-ATPase activity over hemolysate-free control (increase in activity, 0.166±0.029 jmol Pi/mg per 90 min, P < 0.001) ( Table I ). The hemolysate contained no endogenous T4 or T3 detectable by sensitive radioimmunoassay. When T4 (10-l0 M) was added to erythrocyte ghosts in the presence of hemolysate, an increase in enzyme activity of 0.088±0.011 was obtained, compared to enzyme activity without added T4. Table III shows results of a dose-response study of T4 in the presence and absence of hemolysate. The change in enzyme activity with progressive additions of T4 described a parabolic dose-response relationship of thyroid hormone and Ca2+-ATPase activity over a range of thyroid hormone concentrations of 10-4 to 10-'4 M. Maximal hormonal effect was obtained in the absence and presence of hemolysate at 10-1 M T4. The action of T3 on Ca2+-ATPase was also maximal at a T3 concentration of 100-M in both the absence and presence of hemolysate (data not shown). It should be pointed out that interpretation of dose-response studies (Fig. 1) . In the pres- ence of added calmodulin, a significant stimulatory effect of T4 on the enzyme was also observed (Table  I ; Fig. 1 ) and was additive to the action of calmodulin. The use of animal source calmodulin was justified because no interspecies differences in calmodulin structure have been discerned (11) .
When purified calmodulin (100 ng/mg membrane protein) and hypothyroid hemolysate (10 Al/mg membrane protein) were concurrently incubated with erythrocyte membranes, the stimulatory effects of these two agents were additive in both the absence and presence of T4 (Table IV) . That is, Ca2+-ATPase activity obtained with optimal concentrations of calmodulin and T4 was further enhanced when hemolysate was present. Thus, hypothyroid hemolysate may contain enzyme stimulatory factors in addition to calmodulin.
Effect of TFP on T4 stimulation in vitro of Ca2+-ATPase activity. Concentrations of TFP of AM were required to definitively reduce basal Ca2+-ATPase activity of membranes (Fig. 2) . However, low concentrations of TFP (5 and 10 AM) inhibited the T4 effect without decreasing basal enzyme activity. This selective inhibitory action was observed in the presence of purified calmodulin (Fig. 2B ) and when hemolysate was added to membranes ( (Table V) .
Effect of calmodulin antibody on stimulation in vitro of Ca2+-ATPase activity by calmodulin, T4, and hypothyroid hemolysate. In the absence of exogenous (Table VI) .
To further define the antibody effect in this membrane system, we titrated the inhibitory effect of antibody on stimulation of Ca2+-ATPase by calmodulin and T4 (Fig. 3) . In the absence of antibody, the expected stimulation by T4 of Ca2+-ATPase was observed (Fig. 3, vertical panel) . With the addition of antibody at 10 jsg/mg membrane protein (= 10 ug/ml incubation mixture), basal Ca2+-ATPase was reduced and there was no enhancement of enzyme activity by T4. Coincubation of membranes with antibody and purified calmodulin (100 ng/mg membrane protein; molar ratio of antibody:calmodulin, 10:1) resulted in partial restoration of basal membrane activity, as well as T4-stimulated activity, to levels achieved in the absence of antibody (Fig. 3) . When the antibody:calmodulin ratio was reduced to 5:1 (calmodulin concentration, 200 ng/mg membrane protein), there was full restoration of basal Ca2+-ATPase activity and further expression of the additive thyroid hormone effect on the enzyme. When Table VI Ca2+-ATPase in the human erythrocyte is a calcium pump-associated enzyme that maintains intracellular calcium concentration at a low level (15) and is responsive in vitro to physiological concentrations of thy-roid hormone. Human erythrocyte Ca2+-ATPase activity is a model of extranuclear hormone action with inherent advantages over animal cell models that require nanomolar or higher concentrations of iodothyronines to demonstrate actions on transport (16) (17) (18) or maintenance of donor animals on high saturated fat intake prior to ATPase measurements (19) . The present studies examined the hypothesis that calmodulin, the activator protein for Ca2+-ATPase (4, 5, 20) and a regulatory protein for several intracellular enzymes (21) , is essential to the expression of thyroid hormone action on Ca2+-ATPase activity.
TFP is a phenothiazine known to inhibit the action of calmodulin (22) , presumably by binding to the cytoplasmic calmodulin -Ca21 complex which activates membrane-bound Ca2+-ATPase. The addition of TFP to erythrocyte membranes in the present studies eliminated the iodothyronine effect on Ca2+-ATPase and reduced basal enzyme activity in both the presence and absence of purified calmodulin. These observations are consistent with a postulated requirement for calmodulin in hormonal stimulation of Ca2+-ATPase activity and also suggested that our erythrocyte membranes contained residual endogenous calmodulin activity. Recent evidence, however, has shown that TFP is not a wholly specific inhibitor of actions of calmodulin (23 Fig. 2 .
More specific evidence in support of the dependence on calmodulin of thyroid hormone action in the human erythrocyte model was provided by studies carried out with calmodulin antibody. In the absence of thyroid hormone, calmodulin antibody partially inhibited Ca2+-ATPase activity in erythrocyte ghosts (Table VI) , consistent with the presence of endogenous calmodulin in membranes. Calmodulin radioimmunoassay of the membranes subsequently confirmed that small quantities of calmodulin persist in our hypotonically prepared ghosts. The addition of purified calmodulin to antibody-membrane mixtures overcame the suppressive action of antibody on enzyme activity (Table VI) . Stimulation of Ca2+-ATPase activity by T4 was inhibited by antibody, and this inhibition was reversed by the addition of progressively larger quantities of purified calmodulin in the presence of a fixed amount of antibody (Fig. 3) . These observations strongly support the thesis that the iodothyronine effect can be expressed only in the presence of active calmodulin.
Additional studies showed that the antibody effect on thyroid hormone action could not be attributed to the binding of hormone by antibody protein.
Elsewhere we have shown that thyroid hormone and calmodulin do not directly interact (12) , so that it is not likely that stimulation of Ca2+-ATPase activity in vitro by thyroid hormone involves an alteration in the nature of the calmodulin * Ca21 complex. On the basis of the observations reported here and studies of the binding of iodothyronines by erythrocyte membranes (12) , we believe that stimulation by thyroid hormone of erythrocyte Ca2+-ATPase activity requires (a) the presence of membrane-associated calmodulin -Ca2+ complex, as described by Scharff (20) , and (b) the interaction of thyroid hormone with the cell membrane.
Our erythrocyte model is based on the preparation of membranes that are calmodulin poor (4) and are thought to approximate endogenous basal state conditions. The method of membrane preparation and assay for Ca2 -ATPase activity in Tris buffer used in the current studies results in basal enzyme activity estimates that are similar in magnitude to those reported by Strittmatter et al. (9) from which our techniques were derived. Our membrane Ca2+-ATPase activity levels, however, are low compared to results from other methods (4, 5, 15) . The factors that contribute to the differences in enzyme activity include buffer composition both at the time of membrane preparation and at enzyme assay. Farrance and Vincenzi (24) have previously shown that Tris buffer leads to the expression of lower Ca2+-ATPase activities than are observed in the presence of imidazole or histidine buffers (24) used in other laboratories' (5, 25) . The stimulatory effect of T4 on Ca2+-ATPase is demonstrable when the enzyme assay is carried out in Tris (Table  II) , regardless of whether erythrocyte membranes are prepared in Tris or imidazole. However, the in vitro hormone effect is entirely lost when imidazole is used in the enzyme assay. We have recently found that thyroid hormone stimulates calcium efflux from intact human erythrocytes (26) , supporting the functional significance of iodothyronine stimulation of Ca2+-ATPase activity in vitro; these efflux experiments were carried out with cells maintained in Tris buffer. When purified calmodulin and hypothyroid hemolysate were added together to erythrocyte membranes, additive stimulation of Ca2+-ATPase activity was observed. This was the case despite the fact that calmodulin was used at a concentration (100 ng/ml; 6 X 10-9 M) shown to be maximally effective in our laboratory and by others (5) . This suggests that hemolysate contains a stimulator of enzyme activity that is distinct from calmodulin; a noncalmodulin activator has been described in membrane preparations by Mauldin and Roufogalis (27) .
Thyroid Hormone and Human Erythrocyte Ca2+-ATPase 585
